530145-61-0 Usage
Uses
Used in Pharmaceutical Industry:
(R)-3-(((1-Hydroxy-3-phenylpropan-2-yl)aMino)Methyl)-4-nitrobenzonitrile is used as a reactant for the preparation of 3,7-disubstituted-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine compounds. These compounds exhibit farnesyl protein transferase inhibitory activity, which is crucial in the development of drugs targeting various diseases, including cancer.
Used in Chemical Synthesis:
In the field of chemical synthesis, (R)-3-(((1-Hydroxy-3-phenylpropan-2-yl)aMino)Methyl)-4-nitrobenzonitrile serves as an essential building block for creating complex organic molecules with potential applications in various industries, such as pharmaceuticals, agrochemicals, and materials science.
Used in Research and Development:
(R)-3-(((1-Hydroxy-3-phenylpropan-2-yl)aMino)Methyl)-4-nitrobenzonitrile is also utilized in research and development settings to study its chemical properties, reactivity, and potential interactions with other molecules. This information can be valuable for designing new drugs, optimizing synthesis processes, and understanding the underlying mechanisms of various biological processes.
Check Digit Verification of cas no
The CAS Registry Mumber 530145-61-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,3,0,1,4 and 5 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 530145-61:
(8*5)+(7*3)+(6*0)+(5*1)+(4*4)+(3*5)+(2*6)+(1*1)=110
110 % 10 = 0
So 530145-61-0 is a valid CAS Registry Number.
530145-61-0Relevant articles and documents
Development of a Practical Synthesis of a Farnesyltransferase Inhibitor
Shi, Zhongping,Fan, Junying,Kronenthal, David R.,Mudryk, Boguslaw M.
, p. 1534 - 1540 (2018/11/23)
The development of a new and practical synthesis for a farnesyltransferase inhibitor 1 is described. The new route started from 2-nitro-5-cyanotoluene (9) and afforded desired 1 in eight chemical transformations. The key step involved formation of sulfonamide 13 from a hindered β-hydroxyamine 12 through an in situ protection of the hydroxyl group by forming TMS ether. Ultimately, this new route was successfully demonstrated to generate >10 kg of API in 29% overall yield.